(Total Views: 423)
Posted On: 10/02/2025 12:41:43 PM
Post# of 157641
Re: HouseofCards #157543
HouseofCards,
Nice catch about the update today on Clinical Trials for mCRC trial. I like to see the two most recent versions side-by-side to quickly spot the changes. You can see that at this link. Additions are in green and deletions are in red.
https://clinicaltrials.gov/study/NCT06699836?...tent-panel
The following locations were added:
Pacific Hematology Oncology Assoc. in San Francisco (shown as active but NOT recruiting)
Univ. of Nebraska Medical Center in Omaha
Fox Chase Cancer Center in Philadelphia
Quest Clinical Research in San Francisco was deleted, so there are now 6 locations, 5 of which are recruiting. Hopefully, Pacific Hematology will soon start recruiting.
This is consistent with what Dr. JL said in the shareholder letter:
Nice catch about the update today on Clinical Trials for mCRC trial. I like to see the two most recent versions side-by-side to quickly spot the changes. You can see that at this link. Additions are in green and deletions are in red.
https://clinicaltrials.gov/study/NCT06699836?...tent-panel
The following locations were added:
Pacific Hematology Oncology Assoc. in San Francisco (shown as active but NOT recruiting)
Univ. of Nebraska Medical Center in Omaha
Fox Chase Cancer Center in Philadelphia
Quest Clinical Research in San Francisco was deleted, so there are now 6 locations, 5 of which are recruiting. Hopefully, Pacific Hematology will soon start recruiting.
This is consistent with what Dr. JL said in the shareholder letter:
Quote:
Beyond breast cancer, leronlimab continues to advance in the treatment of metastatic Colorectal Cancer (mCRC). Enrollment in our Phase II study is underway with five sites initiated and several more onboarding in the next several weeks.
(16)
(0)
